Literature DB >> 16209068

Interferons in the treatment of solid tumors.

Stergios Moschos1, Sai Varanasi, John M Kirkwood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16209068     DOI： 10.1007/0-387-24361-5_9

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  11 in total

Review 1.  Type I interferons in anticancer immunity.

Authors:  Laurence Zitvogel; Lorenzo Galluzzi; Oliver Kepp; Mark J Smyth; Guido Kroemer
Journal:  Nat Rev Immunol       Date:  2015-06-01       Impact factor: 53.106

2.  Activation of protein kinase C{eta} by type I interferons.

Authors:  Amanda J Redig; Antonella Sassano; Beata Majchrzak-Kita; Efstratios Katsoulidis; Hui Liu; Jessica K Altman; Eleanor N Fish; Amittha Wickrema; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

3.  A phase II trial of doxorubicin and interferon alpha 2b in advanced, non-medullary thyroid cancer.

Authors:  Athanassios Argiris; Sanjiv S Agarwala; Michalis V Karamouzis; Lynn A Burmeister; Sally E Carty
Journal:  Invest New Drugs       Date:  2007-10-02       Impact factor: 3.850

4.  Expression and regulatory effects of murine Schlafen (Slfn) genes in malignant melanoma and renal cell carcinoma.

Authors:  Evangelos Mavrommatis; Ahmet Dirim Arslan; Antonella Sassano; Youjia Hua; Barbara Kroczynska; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2013-10-02       Impact factor: 5.157

Review 5.  IFN-λ cancer immunotherapy: new kid on the block.

Authors:  Ahmed Lasfar; Helen Gogas; Andrew Zloza; Howard L Kaufman; John M Kirkwood
Journal:  Immunotherapy       Date:  2016-07       Impact factor: 4.196

6.  Zebularine elevates STING expression and enhances cGAMP cancer immunotherapy in mice.

Authors:  Junzhong Lai; Yajuan Fu; Shuoran Tian; Shanlu Huang; Xuan Luo; Lili Lin; Xing Zhang; Hanze Wang; Zhang Lin; Heng Zhao; Shujin Lin; Junhong Zhao; Shan Xu; Daliang Li; Shaoli Cai; Luna Dong; Jing Qian; Jiadi Liang; Qiumei Li; Yong Zhang; Jiqiang Fan; Robert Balderas; Qi Chen
Journal:  Mol Ther       Date:  2021-02-09       Impact factor: 11.454

Review 7.  Interferon lambda: a new sword in cancer immunotherapy.

Authors:  Ahmed Lasfar; Walid Abushahba; Murugabaskar Balan; Karine A Cohen-Solal
Journal:  Clin Dev Immunol       Date:  2011-12-06

Review 8.  STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment.

Authors:  Federica Laudisi; Fabio Cherubini; Giovanni Monteleone; Carmine Stolfi
Journal:  Int J Mol Sci       Date:  2018-06-16       Impact factor: 5.923

9.  Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica.

Authors:  Agnieshka M Agasing; Qi Wu; Bhuwan Khatri; Nadja Borisow; Klemens Ruprecht; Alexander Ulrich Brandt; Saurabh Gawde; Gaurav Kumar; James L Quinn; Rose M Ko; Yang Mao-Draayer; Christopher J Lessard; Friedemann Paul; Robert C Axtell
Journal:  Nat Commun       Date:  2020-06-05       Impact factor: 14.919

Review 10.  Chaperone-Mediated Autophagy in the Liver: Good or Bad?

Authors:  Srikanta Dash; Yucel Aydin; Krzysztof Moroz
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.